Eran Ovadya

Direttore Finanziario/CFO presso NUREXONE BIOLOGIC INC.

Patrimonio netto: 198 475 $ in data 30/04/2024

Health Technology

Posizioni attive di Eran Ovadya

Società	Posizione	Inizio	Fine
NUREXONE BIOLOGIC INC.	Direttore Finanziario/CFO	15/06/2022	-

Società	Posizione	Inizio	Fine
VVT Medical Ltd.	Direttore Finanziario/CFO	-	-
Silexion Therapeutics Ltd. Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.	Direttore Finanziario/CFO	-	-

Distribuzione geografica

Israele	3
Canada	2

Posizioni

Director of Finance/CFO

Settori

Health Technology

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
NUREXONE BIOLOGIC INC.	Health Technology

Aziende private	2
Silexion Therapeutics Ltd. Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.	Health Technology
VVT Medical Ltd.